-
Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations
Neeta Ratanghayra
December 20, 2024
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
-
Making Cell and Gene Therapy Affordable
Suzanne Elvidge
November 04, 2024
Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
-
Key Considerations for Cold Chain Distribution in Cell Therapy
Saher Haider
October 16, 2024
In this article, we focus on the key factors that influence cold chain distribution in cell therapy, including temperature stability, packaging and handling challenges, and compliance with regulatory standards.
-
Advancing Cryogenic Cold Chain Technology for Cell Therapy Products
Saher Haider
October 15, 2024
Unlike conventional temperature-sensitive pharmaceutical products, cell therapy products have the most stringent requirements for cold chain logistics.In this article, we will dive deeper into cryogenic technology used at every step of the cold chain supp
-
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
PharmaSources
August 26, 2024
Avantor, Inc. has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024.
-
NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling
Biotech Newswire
August 09, 2024
Aber Instruments (Aber) is delighted to introduce its new OPTURA® PALM® handheld biomass sensor.
-
Optimizing Cold Chain Logistics for Cell Therapy Products
Saher Haider
August 06, 2024
In this article, we will explore the logistical challenges posed by this immensely sensitive class of Cell therapy products, and how they can be maintained.
-
Human T-Cell Leukemia Virus (HTLV) Treatments: A Focus on Cepharanthine
David Orchard-Webb
August 01, 2024
Human T-cell leukemia virus is a retrovirus that infects T-cells. One promising therapeutic agent is Cepharanthine, a natural alkaloid with antiviral properties.
-
Optimizing Biotherapeutic Production: The Power of Cell Line Engineering
Shruti Talashi
August 01, 2024
Cell line development has emerged as a cornerstone in the biopharmaceutical industry.
-
iotaSciences Raises Equity Financing Round to Drive Further Business Expansion for Its Automated Single-Cell Biology Handling Technologies
Biotech Newswire
August 01, 2024
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform.